ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)
China · Delayed Price · Currency is CNY 24.75
+0.83 (3.47%)
Last updated: Jul 16, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Self-Selling Products | 237.69M | Log In | Log In | Log In | Log In | Upgrade |
Self-Selling Products Growth | -4.90% | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredient | 174.36M | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredient Growth | 9.03% | Log In | Log In | Log In | Log In | Upgrade |
Trade | 1.23M | Log In | Log In | Log In | Log In | Upgrade |
Trade Growth | -16.81% | Log In | Log In | Log In | Log In | Upgrade |
Other Business | 1.03M | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | 727.26% | Log In | Log In | Log In | Log In | Upgrade |
L -Carnitine | - | Log In | Log In | Log In | Log In | Upgrade |
L -Carnitine Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Intermediates - Anti-tumor Drug Intermediates | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Intermediates - Anti-tumor Drug Intermediates Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Intermediates - Veterinary Drug Intermediates | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Intermediates - Veterinary Drug Intermediates Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Intermediates - Anti-infective Drug Intermediates | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Intermediates - Anti-infective Drug Intermediates Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Intermediates - Neuromedicine Intermediates | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Intermediates - Neuromedicine Intermediates Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Intermediates - Other Pharmaceutical Intermediates | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Intermediates - Other Pharmaceutical Intermediates Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Technical Services | - | Log In | Log In | Log In | Log In | Upgrade |
Technical Services Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
China | 264.94M | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 28.70% | Log In | Log In | Log In | Log In | Upgrade |
Foreign | 149.37M | Log In | Log In | Log In | Log In | Upgrade |
Foreign Growth | -27.35% | Log In | Log In | Log In | Log In | Upgrade |
Europe | - | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | - | Log In | Log In | Log In | Log In | Upgrade |
North America | - | Log In | Log In | Log In | Log In | Upgrade |
North America Growth | - | Log In | Log In | Log In | Log In | Upgrade |
India | - | Log In | Log In | Log In | Log In | Upgrade |
India Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |